| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Jan 25 | ELDN Eledon Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 8,575 | 0.00 | 8,575 |
| 10 Jan 25 | ELDN Eledon Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.04 | 77,175 | 311.79 k | 77,175 |
| 23 May 24 | EBS Emergent BioSolutions | Common Stock | Grant | Acquire A | No | No | 0 | 17,430 | 0.00 | 59,872 |
| 23 May 24 | EBS Emergent BioSolutions | Stock Option Common Stock | Grant | Acquire A | No | No | 5.02 | 25,748 | 129.25 k | 25,748 |
| 7 Feb 24 | SNDX Syndax Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 17,000 | 0.00 | 65,000 |
